BREAKTHROUGH BIOSENSOR TECHNOLOGIES

ABOUT US

bialoom is a deep tech start-up established in Nicosia, Cyprus with a vision to grow into a global diagnostics game changer. bialoom finds itself at the cross road of silicon photonics, plasmonics and in-vitro diagnostics to solve global diagnostic challenges.

OUR MISSION

Our mission is to develop the necessary diagnostic tools for early diagnosis and treatment of acute infections at the point of need.

SOLUTION

Our solution leverages proprietary silicon plasmo-photonic biosensor technology to deliver powerful and affordable biochips embedded in a disposable cartridge. Our multi-functional biochip is capable of quantifying complicated biomarker signatures from the patient blood for faster and evidence-based diagnosis and treatment of severe infections. 

SENSITIVITY

Use proprietary plasmonic interferometric sensors for super-sensitive detection of multiple critical biomarkers.

SMALL VOLUMES OF ANALYTE

Micrometer scale footprint of the sensing area allows tests from microliter scale analytes.

 MULTIPLEXING AT LOW COST

Use standard semiconductor technology (CMOS) for low-cost volume manufacturing of multi-sensor chip.

INTELLIGENCE

We are looking for partnerships and collaborations in the fields of Artificial Intelligence and Machine Learning to analyze the outcomes of personalized bialoom’s tests with patients medical records, demographics and medical statistics.

PARTNERS

GRAVITY VENTURES


Aristotle University of Thessaloniki


AMO GmbH


RWTHAachen


THE TEAM

DIMITRIS TSIOKOS, PhD

Co-founder & CEO

Dimitris is an Electronic Engineering graduate from the University of Southampton. His commitment in photonic science led him to the completion of an MSc in Photonics from Imperial College London and a PhD in photonics at the National Technical University of Athens. Dimitris held various research positions developing photonic technologies for telcommunications, computer interconnects and bio-applications at the Centre for Research and Technology Hellas, the Aristotle University of Thessaloniki in Greece and more. His passion for innovation in health and medical technologies led him to the founding of bialoom. His technological interest spin around silicon photonics, plasmonics, biosensing and point of care diagnostics. Dimitris is an EITHealth alumni where he was trained in Healthtech innovation and entrepreneurship.

THANASIS MANOLIS

Principal Engineer

Thanasis is a computer science graduate from Aristotle university of Thessaloniki. He received his Master of Science in networks, communication and system architecture from the computer science department of the Aristotle University of Thessaloniki. His diploma thesis focused on the design and experimental characterization of plasmonic waveguides integrated with silicon photonics. To pursue his PhD Thanasis joined the WinPhos research group at the Center for Interdisciplinary Research and Innovation (CIRI) of the Aristotle University of Thessaloniki as a research associate, participating in a series of EU funded research projects. Thanasis has been developing silicon photonic and plasmonic based solutions for computer interconnects and biosensing applications for more than 3 years, strongly focusing on application-driven R&D. His technological interests include photonic and plasmonic integrated circuits for biosensors and next generation point of care diagnostics.

STELLA TAKA, PhD

Clinical Operations

Stella is a molecular biologist, with over 10 years of experience in molecular diagnostic field, specifically to allergy diagnosis and infectious diseases. Prior to bialoom Stella has been a researcher and entrepreneur in the field of diagnostics. She is Founder & CEO of «StArtBio P.C.», an innovative diagnostic services company targeting the development of new allergy diagnosis methods since 2017. During her MSc studies in Molecular Medicine in National and Kapodistrian University of Athens Medical school (NKUA) Stella focused in functional genomics and proteomics analysis. Her PhD studies then focused on immunological response of macrophages under Mycobacterium paratuberculosis infection, a bacterium relating to Inflammatory Bowel Diseases, (IBDs). She is also a research fellow at the Allergy Department, 2nd Pediatric Clinic in National, Medical school (NKUA). During last years, her main research activities are focused on the interaction between gut and respiratory bacteria/viruses and the innate immune system.

PANAYIOTIS PHILIMIS, PhD

Gravity Incubator – CyRIC

Panayiotis is a Mechanical Engineer with PhD in Manufacturing Systems and AI. He has past experience in product testing, certification and Quality management with international multi-million sales of scientific and industrial instrumentation. He has over 20 years experience in the development of disruptive products and managed more than 100 R&D and Industry projects with budgets exceeding 100million Euro. He is the founder and CEO of CyRIC the certified Business Innovation Center (BIC) of Cyprus and Gravity Ventures, a venture building incubator based in Nicosia. His expertise extends from creation of business models for commercialization and investments for early stage Startups and Scale-ups. He is president of the Cyprus Association of Research and Innovation Enterprises (CARIE), member of the Cyprus Business Angels Network (CyBAN), member of the BoD, of the European Business Network (EBN), the Nicosia Chamber of Commerce and Industry (NCCI), the Research Promotion Foundation (RPF) and the Cyprus Academic and Research Network (CyNE).

ADVISORY BOARD

<Under construction>

WORK WITH US

We are sorry, there are no vacancies for now, please visit us again in the future.

Get in Touch

Learn more about our unique solutions!

Bialoom has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No [888337]

H2020-SMEINST-888337_SepsiCare

bialoom is funded by the Cyprus Research and Innovation Foundation through the “Proof of Concept for Technological and Knowledge Applications” project LOTTO (Grant No CONCEPT/0618/0038)

European Regional Development Fund and the Research and Innovation Foundation of Cyprus (LOTTO (CONCEPT/0618/0038))